Mandragora officinarum (botany)

Species-Specific Alkaloid Data

Mandragora officinarum has been more extensively analyzed chemically than other Mandragora species. Published analyses show:

• Total alkaloid content in dried root: 0.2–0.5%, dominated by hyoscyamine, with scopolamine typically present at 20–40% of total alkaloid
• Leaves: Lower total alkaloid, approximately 0.1–0.2%
• Berries: Variable, generally lower alkaloid content than root; the sweet berries were consumed in antiquity but are not safe in quantity

Mandragorine (3-tropyl tiglate) was first isolated from M. officinarum and gives the genus its pharmacological distinction from Datura; its specific contribution to the plant's effect profile relative to hyoscyamine and scopolamine has not been fully characterized but is believed to contribute sedative activity.

Seasonal and Geographic Variation

Alkaloid content and ratio vary seasonally (highest in root during dormancy) and geographically across the species' range. Plants from different Mediterranean populations may have substantially different alkaloid profiles, which partly explains inconsistencies in historical descriptions of potency.

Historical Pharmaceutical Preparations

Ancient and medieval preparations of M. officinarum used in Western medicine typically involved:

• Root wine: Root material macerated in wine (the "vinum mandragore" of medieval pharmacy)
• Decoction: Root boiled in water or wine
• Soporific sponge: Combined with other analgesics for surgical sedation
• Topical application: Root preparations applied as liniments for localized pain

Botanical History and Identification

Mandragora officinarum was one of the most carefully described and debated plants in ancient and medieval botanical literature. The challenge of correctly identifying it across multiple description traditions — Greek, Latin, Arabic, and medieval Latin — occupied botanists for centuries, and the history of its identification is a microcosm of the history of Western botany.

Theophrastus (Historia Plantarum, circa 300 BCE) described two varieties distinguishable by leaf size, which he called "male" and "female" mandrake. Dioscorides (De Materia Medica, 60 CE) provided more detailed description of both varieties, their habitat, the distinctive root, and multiple pharmaceutical preparations. Pliny the Elder (Naturalis Historia) described the plant's narcotic and analgesic properties. These three sources — along with Galen's endorsement of Mandrake in pharmaceutical practice — established M. officinarum as canonical in Western medicine for the subsequent 1,500 years.

The Arabic tradition preserved and extended the Greek knowledge: Avicenna (Canon of Medicine, circa 1025 CE) devoted substantial attention to Mandrake's pharmaceutical applications, recommending it for pain, insomnia, and as a surgical anesthetic. The Arabic designation yabruh (from the Aramaic) gave the plant an alternative name in medieval European translations.

The Illustrated Herbals

The history of Mandrake in illustrated herbals represents one of the most distinctive and evolving traditions in botanical art. The earliest illustrated herbals — including the famous Vienna Dioscurides manuscript of 512 CE — depicted Mandrake with characteristic human-form roots, already suggesting the mythological elaboration of the human-shaped taproot that would become central to medieval lore.

Later medieval herbals — the Gart der Gesundheit (1485), the Hortus Sanitatis (1491), and numerous manuscript herbals — typically depicted Mandrake roots as distinctly anthropomorphic, often with a man's face in the "male" variety and a woman's face in the "female." These illustrations were both documentary (recording genuine observation of the sometimes humanoid root form) and mythological (reinforcing and elaborating the magical doctrine of signatures, which held that a plant's physical appearance indicated its medical use).

Doctrine of Signatures and Magical Medicine

The concept of the "Doctrine of Signatures" — the belief that God had marked medicinal plants with physical signs indicating their healing properties — found its most dramatic application in Mandrake. The human-form root was interpreted as indicating that Mandrake was particularly suited to treating whole-body human ailments. This interpretation, elaborated by Paracelsus (16th century) and others, placed Mandrake at the center of a system of magical medicine that blended pharmacological knowledge with Neoplatonic philosophy and biblical symbolism.

Paracelsus devoted extensive attention to Mandrake in his pharmaceutical writing, including discussing the making of the "alraune" talisman from the root. The Paracelsian tradition continued to propagate Mandrake's magical reputation into the early modern period, even as scientific medicine was beginning to question the plant's reliability.

Legal and Commercial History

The trade in Mandrake root was commercially significant enough to generate fraudulent practices — sellers of "mandrake roots" would sometimes carve other roots (bryony root was commonly used) into human forms to satisfy demand from customers who could not distinguish genuine Mandrake. This fakery was documented and complained about in multiple period sources, indicating both the scale of the market and the difficulty of botanical identification before Linnaean taxonomy.

The combination of genuine medicinal value (real analgesia and sedation from the alkaloids), spectacular mythological history, and commercial fraudulence around the product creates a uniquely complex historical record for M. officinarum — one that spans pharmacology, mythology, theology, art history, and economic history simultaneously.